IP Library Granted Patent US 10,953,170
Granted Patent B2
US 10,953,170 · App. 15/728,172 · Granted Mar 23, 2021

Apparatus for treating asthma using neurotoxin

Inventors: Mark E. Deem (Mountain View, CA); Hanson S. Gifford, III (Woodside, CA)
Assignee: Nuvaira, Inc.
A61M16/00A61B1/2676A61M5/30A61M11/00A61M25/10A61B1/018A61B1/04A61B1/0661A61M5/1452A61M5/162A61M25/0084A61M2025/0086A61M2025/105A61M2202/049A61M2210/1035
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,953,170
App. No.
15/728,172
Granted
Mar 23, 2021
Kind
B2
Abstract

Apparatus and methods for providing intrabronchial delivery of a treatment fluid to control the effects of a bronchial condition. The apparatus can include a shaft having proximal and distal ends and a fluid injection assembly disposed on the distal end. The fluid injection assembly can be a deployable needle assembly, a rotating needle assembly, a needle-less injection assembly, or a nebulizer assembly.

Claims (12)

1. A delivery device for delivering a pressurized treatment fluid to a target treatment area of a wall of an airway to treat a bronchial condition, the target treatment area extending only a portion of a circumference of the airway, the delivery device comprising:

a shaft having a proximal end including an inlet port, a distal end and a lumen extending between the inlet port and the distal end;

a needle-less injection assembly coupled to the distal end of the shaft on a first side of the shaft, and comprising at least one fluid injector in fluid communication with the lumen of the shaft; and

a deflection mechanism disposed on a side of the shaft opposite the needle-less injection assembly, the deflection mechanism being configured to align the shaft with the target treatment area and urge the shaft and the at least one fluid injector adjacent to and in contact with the wall of the airway at a first contact area radially inward from the target treatment area by contacting the wall of the airway at a second contact area, the second contact area being opposite the airway from the first contact area, wherein the deflection mechanism is configured to contact the second contact area and not the first contact area, and

wherein the at least one fluid injector is configured to directly inject the pressurized treatment fluid from the lumen across an epithelium of the wall of the airway at the first contact area and to the target treatment area while the at least one fluid injector is in contact with the wall of the airway to alter the target treatment area so as to treat the bronchial condition.

2. The delivery device of claim 1 , wherein the deflection mechanism is an inflatable balloon.

3. The delivery device of claim 1 , wherein the at least one fluid injector comprises at least one port configured to be placed in apposition to the target treatment area and to deliver a pressurized gas across the epithelium and to the target treatment area.

4. The delivery device of claim 1 , wherein the needle-less injection assembly comprises a plurality of needle-less injectors arranged along the shaft so as to be placed in apposition to the wall of the airway in different locations along the airway at the first contact area.

5. The delivery device of claim 1 , wherein the shaft is either pre-curved or actively curved with an activation mechanism to urge the at least one fluid injector adjacent to or against the wall of the airway at the first contact area.

6. The delivery device of claim 1 , wherein the pressurized treatment fluid comprises a neurotoxin.

7. A system comprising the delivery device of claim 1 , further comprising a bronchoscope having proximal and distal ends, a lumen extending therebetween, wherein the shaft is dimensioned to slidably pass through the lumen of the bronchoscope.

8. A system comprising the delivery device of claim 1 , further comprising a controller coupled to the proximal end of the shaft, and configured to deliver a desired dose of the pressurized treatment fluid to the target treatment area.

Assignments (8)
SECURITY INTEREST Recorded Oct 16, 2024
From: NUVAIRA, INC.
To: INNOVATUS LIFE SCIENCES LENDING FUND 1, LP
Reel/Frame 069175/0918 →
SECURITY INTEREST Recorded Dec 21, 2021
From: NUVAIRA, INC.
To: INNOVATUS LIFE SCIENCES LENDING FUND 1, LP
Reel/Frame 058561/0979 →
CHANGE OF NAME Recorded Jan 5, 2018
From: HOLAIRA, INC.
To: NUVAIRA, INC.
Reel/Frame 045012/0063 →
CHANGE OF NAME Recorded Nov 29, 2017
From: INNOVATIVE PULMONARY SOLUTIONS, INC.
To: HOLAIRA, INC.
Reel/Frame 044531/0203 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 27, 2017
From: THE FOUNDRY LLC
To: INNOVATIVE PULMONARY SOLUTIONS, INC.
Reel/Frame 044223/0029 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 21, 2017
From: THE FOUNDRY, INC.
To: THE FOUNDRY, LLC
Reel/Frame 044191/0286 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE NAME PREVIOUSLY RECORDED AT REEL: 043816 FRAME: 0683. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Oct 10, 2017
From: DEEM, MARK E.; GIFFORD, HANSON S.
To: THE FOUNDRY INC.
Reel/Frame 044173/0235 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 9, 2017
From: DEEM, MARK E.; GIFFORD, HANSON S.
To: NUVAIRA, INC.
Reel/Frame 043816/0683 →
Continuity (5)
Division 15155641 · May 16, 2016
Continuation 13669305 · Nov 5, 2012
Continuation 11446043 · Jun 1, 2006
Continuation 10437882 · May 13, 2003
Related Publication 20180028748A1 · Feb 1, 2018